Canadian Universities' Study Reveals Financial Value of Antibiotic Stewardship Programs in Primary Care

Canadian Researchers Highlight Economic and Clinical Gains from Primary Care Antibiotic Stewardship

A groundbreaking study led by researchers from leading Canadian universities has demonstrated the substantial financial value of antibiotic stewardship programs (ASPs) in primary care settings. Published in JAMA Network Open on March 13, 2026, the research analyzed a mailed audit and feedback intervention targeting nearly 5,000 primary care physicians in Ontario. The program, costing just $5.50 per physician, generated $43.03 in savings per physician, yielding a return on investment (ROI) of $8.82 for every dollar spent.

This intervention focused on reducing unnecessary antibiotic prescriptions for patients aged 65 and older, a group particularly vulnerable to adverse events like Clostridioides difficile infections. By linking trial data with comprehensive health care utilization records from the Institute for Clinical Evaluative Sciences (ICES), the team quantified not only direct cost reductions from fewer antibiotics but also savings from averted harms such as diarrhea. Scaling this to all 40,000 primary care physicians across Canada could amplify the ROI to $16.82, underscoring a scalable path to combat antimicrobial resistance (AMR) while bolstering health system sustainability.

The study's implications extend to public health policy, where ASPs—systematic efforts to optimize antibiotic selection, dosage, and duration—emerge as low-cost, high-impact tools. With AMR projected to cause up to 40% resistance in first-line treatments by mid-century in Canada, such university-driven innovations offer timely evidence for investment.

Understanding Antibiotic Stewardship Programs in Primary Care

Antibiotic stewardship programs represent coordinated interventions designed to improve antibiotic use by promoting appropriate prescribing practices. In primary care—the first line of defense for most infections—these programs address overprescribing, a key driver of AMR. In Canada, primary care physicians prescribe over 80% of community antibiotics, often for viral illnesses like acute respiratory infections where they provide no benefit.

ASPs typically involve education, audit and feedback, rapid diagnostics, and peer comparisons. The intervention in this study used mailed reports comparing a physician's prescribing rates to peers, a behavioral nudge proven effective in changing habits without mandating restrictions. This approach aligns with Canada's Pan-Canadian Action Plan on AMR, emphasizing primary care as a priority sector.

Historically, ASPs have focused on hospitals, but primary care lags due to fragmented data and incentives. University researchers are bridging this gap, leveraging linked administrative databases to deliver actionable insights.

The Methodology Behind the Groundbreaking Trial

The study stemmed from a pragmatic randomized controlled trial involving 4,879 Ontario family physicians. Participants received quarterly mailed reports detailing their antibiotic prescribing rates for seniors compared to top-performing peers, with optional pledges to improve. Researchers from the University of Ottawa's Ottawa Hospital Research Institute and ICES integrated this with provincial health data to model costs over one year.

• Direct antibiotic costs: Reduced by $55 per physician.
• Adverse event costs (e.g., diarrhea): $264 savings.
• Program delivery: Printing, postage, and analysis totaled $5.50.

Sensitivity analyses confirmed robustness, even accounting for potential undertreatment harms. Probabilistic modeling showed a 93.2% chance of positive ROI, making a compelling case for replication.

Quantifying the Financial Returns: ROI Breakdown

The economic model revealed multifaceted savings. Antibiotic expenditures dropped significantly, as physicians curbed prescriptions for low-value indications. Reduced adverse events—common with antibiotics like diarrhea from C. difficile—cut downstream costs like hospitalizations.

Per physician:

Clinical Impacts: Patient Safety and Resistance Prevention

Beyond finances, the program enhanced patient safety by minimizing harms. Antibiotics contribute to 20-30% of emergency visits for adverse drug events in seniors. By averting these, the intervention protected vulnerable populations while curbing AMR—a threat linked to 2,700 Canadian deaths annually, projected to rise.

Spillover effects were noted in prior studies, where senior-focused feedback improved prescribing across ages. University-led trials like this provide evidence for integrating ASPs into electronic health records.

Photo by LEDC on Unsplash

Key Universities Fueling Canada's ASP Research

This study exemplifies collaborative university efforts. Lead author Li Bai from the Ottawa Hospital Research Institute (affiliated with University of Ottawa) partnered with University of Toronto's Leslie Dan Faculty of Pharmacy and ICES researchers. Western University and Laval University contributed expertise in economics and behavior change.

These institutions train the next generation of stewardship experts through programs in public health and pharmacy. For students rating professors or seeking advice, explore Rate My Professor or higher-ed career advice. Links to Canadian academic jobs abound for public health roles.

AMR Landscape in Canadian Primary Care

Canada faces escalating AMR: 26% of infections resistant to first-line antibiotics in 2018, forecasted to 40%. Primary care drives 65% of prescriptions, with overuse for respiratory infections. Government reports emphasize ASPs, yet implementation varies provincially.

University surveillance networks like CPCSSN track trends, informing interventions. Economic pressure from AMR—billions in extra costs—makes stewardship urgent. Read the full JAMA study.

Challenges and Barriers to Widespread Adoption

Despite promise, hurdles persist: data silos, physician time constraints, and rural-urban disparities. Feedback must be timely and actionable. Universities advocate for national frameworks, like CANBuild-AMR.

• Limited funding for primary care ASPs vs. hospitals.
• Resistance to change from habituated prescribing.
• Need for interprovincial data sharing.

Solutions include digital tools and incentives, researched at U of T and Ottawa U.

Policy Recommendations and National Rollout Potential

Authors urge policymakers to fund A&F nationally, projecting $16.82 ROI. Aligns with Pan-Canadian AMR Plan Year 2 progress. Provinces like Ontario lead; others can follow. For careers shaping policy, visit faculty positions in epidemiology.

CIDRAP coverage amplifies calls for action.

Future Outlook: Innovations from Canadian Academia

Ongoing trials like CANBuild-AMR expand feedback nationally. Universities explore AI for real-time audits and point-of-care tests. With AMR threats evolving—e.g., Candida auris—academic research remains pivotal.

Prospective students in pharmacy or public health can contribute; see scholarships.

Photo by Andy Holmes on Unsplash

Practical Steps for Primary Care Providers and Clinics

• Request prescribing audits from provincial networks.
• Adopt peer benchmarking tools.
• Train staff via university CME programs.
• Monitor local resistance patterns.

These steps yield quick wins, as proven. For professional growth, explore academic CV tips.

Conclusion: Stewardship as Smart Investment

Canadian universities' rigorous research validates ASPs as economically viable weapons against AMR. With proven ROI and patient benefits, scaling is imperative. Institutions like U of Ottawa and U of T lead the charge—future leaders can join via university jobs, higher ed jobs, or rate my professor. Invest in stewardship today for healthier tomorrows.